Market capitalization | $25.67b |
Enterprise Value | $24.59b |
P/E (TTM) P/E ratio | 8.60 |
EV/FCF (TTM) EV/FCF | 2.51 |
EV/Sales (TTM) EV/Sales | 1.19 |
P/S ratio (TTM) P/S ratio | 1.25 |
P/B ratio (TTM) P/B ratio | 1.74 |
Dividend yield | 1.52% |
Last dividend (FY24) | $1.00 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
22 Analysts have issued a Synchrony Financial forecast:
22 Analysts have issued a Synchrony Financial forecast:
Sep '24 |
+/-
%
|
||
Revenue | 20,582 20,582 |
26%
26%
|
|
Gross Profit | 16,495 16,495 |
23%
23%
|
|
EBITDA | 12,247 12,247 |
28%
28%
|
EBIT (Operating Income) EBIT | 4,951 4,951 |
30%
30%
|
Net Profit | 3,165 3,165 |
33%
33%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Synchrony Financial engages in the provision of consumer financial services. It operates through three sales platforms: Retail Card, Payment Solutions, and CareCredit. The Retail Card platform is a provider of private label credit cards, and also provides Dual Cards and small-and medium-sized business credit products. The Payment Solutions platform is a provider of promotional financing for major consumer purchases, offering private label credit cards and instalment loans. The CareCredit platform is a provider of promotional financing to consumers for elective healthcare procedures or services, such as dental, veterinary, cosmetic, vision and audiology. The company was founded on September 12, 2003 and is headquartered in Stamford, CT.
Head office | United States |
CEO | Brian Doubles |
Employees | 20,000 |
Founded | 2003 |
Website | www.synchrony.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.